By: Benzinga
UPDATE: Jefferies Raises PT on Allergan on Q4 EPS
In a report published Wednesday, Jefferies reiterated its Hold rating on Allergan (NYSE: AGN ), and raised its price target from $95.00 to $100.00. Jefferies noted, “AGN did what it does best: beat EPS and gave strong guidance. Q4 adj-EPS of $1.15 ‘missed', but adjusting for the expected R&D tax
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here